Modulatori enzimatici
I modulatori enzimatici sono composti che possono aumentare o inibire l'attività degli enzimi, regolando così la velocità delle reazioni biochimiche. Questi modulatori svolgono un ruolo cruciale nel controllo delle vie metaboliche, della segnalazione cellulare e di vari processi fisiologici. I modulatori enzimatici sono ampiamente utilizzati nella ricerca e nello sviluppo di farmaci per studiare le funzioni enzimatiche e sviluppare agenti terapeutici. Presso CymitQuimica, offriamo una gamma completa di modulatori enzimatici di alta qualità per supportare la vostra ricerca nella regolazione enzimatica e nella scoperta di farmaci.
Sottocategorie di "Modulatori enzimatici"
Trovati 693 prodotti di "Modulatori enzimatici"
Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
JNJ 38877605
CAS:<p>Potent inhibitor of c-Met catalytic activity. Selective over other tyrosine and serine-threonine kinases (600-fold selectivity). Ability to block constitutive or HGF-stimulated phosphorylation of c-Met demonstrated in vitro. JNJ 38877605 reduces radiation-induced invasion, apoptosis and proliferation of cancer cells in vitro.</p>Formula:C19H13F2N7Purezza:Min. 95%Colore e forma:SolidPeso molecolare:377.12005Dabrafenib mesylate
CAS:<p>Inhibitor of B-Raf kinase mutant</p>Formula:C23H20F3N5O2S2·CH4O3SPurezza:Min. 95%Colore e forma:White/Off-White SolidPeso molecolare:615.67Mirodenafil dihydrochloride
CAS:<p>Mirodenafil dihydrochloride is a potent phosphodiesterase-5 (PDE5) inhibitor, which is a synthetic compound with a primarily chemical origin. Its mode of action involves the inhibition of the enzyme PDE5, which predominantly resides in the smooth muscle cells lining blood vessels. By inhibiting PDE5, Mirodenafil dihydrochloride effectively increases the levels of cyclic guanosine monophosphate (cGMP), leading to the relaxation of smooth muscle tissues and vasodilation.</p>Formula:C26H39Cl2N5O5SPurezza:Min. 97 Area-%Colore e forma:White PowderPeso molecolare:604.59 g/molMefenamic acid
CAS:<p>COX1 inhibitor; blocker of Ca2+-activated non-selective cation channels</p>Formula:C15H15NO2Purezza:Min. 99 Area-%Colore e forma:White PowderPeso molecolare:241.29 g/molMetformin HCl - Bio-X ™
CAS:Metformin is a widely used anti-hyperglycemic (anti-diabetic) agent for the treatment of type 2 diabetes mellitus. This is due to it decreasing blood glucose by decreasing hepatic glucose product by activation of the AMP-activated protein kinase AMPK. Studies have also demonstrated Metformin to have anti-cancer activity, attributed to several mechanisms such as inhibition of mammalian target of rapamycin (mTOR), cancer stem cells and inflammation.Formula:C4H11N5•HClPurezza:Min. 95%Colore e forma:PowderPeso molecolare:165.62 g/molLenvatinib mesylate - Bio-X ™
CAS:Lenvatinib is an anti-cancer drug that is a multi-kinase inhibitor for VEGFR1, VEGFR2 and VEGFR. It has been shown to be effective against several cancers such as thyroid cancer and is currently in clinical trials for the treatment of leukaemia and prostate cancer. Furthermore, Lenvatinib also inhibits the activity of other protein kinases, including those involved in inflammatory responses.Formula:C22H23ClN4O7SPurezza:Min. 95%Colore e forma:PowderPeso molecolare:522.96 g/molPexidartinib
CAS:<p>Inhibitor of CSF1R receptor</p>Formula:C20H15ClF3N5Purezza:Min. 95%Colore e forma:PowderPeso molecolare:417.81 g/molTH 5487
CAS:<p>Specific inhibitor of 8-oxoguanine glycosylase OGG1 with IC50 in submicromolar range. The compound inhibits binding of OGG1 to its substrate 8-oxoguanine, a guanine analog generated in the presence of reactive oxygen species (ROS). It was shown that TH5487 decreases inflammation level by inhibiting the base excision DNA repair in mice and altering the OGG1 chromatin dynamics. The compound also has implications in cancer biology since OGG1 inhibitors sensitise tumours to chemotherapy.</p>Formula:C19BrH18IN4O2Purezza:Min. 95%Colore e forma:SolidPeso molecolare:541.18 g/molPitavastatin lactone
CAS:<p>Inhibitor of HMG-CoA reductase</p>Formula:C25H22FNO3Purezza:Min. 95%Colore e forma:PowderPeso molecolare:403.45 g/mol(R)-Lansoprazole
CAS:<p>Gastric proton pump inhibitor</p>Formula:C16H14F3N3O2SPurezza:Min. 95%Colore e forma:PowderPeso molecolare:369.36 g/molN-ω-Propyl-L-arginine
CAS:Neuronal selective nitric oxide synthase inhibitorFormula:C9H20N4O2Purezza:Min. 95%Colore e forma:White PowderPeso molecolare:216.28 g/molZoledronic acid, disodium salt, tetrahydrate
CAS:<p>Farnesyl pyrophosphate synthase inhibitor; hepatic de novo lipogenesis inhibitor</p>Formula:C5H8N2Na2O7P2·4H2OPurezza:Min. 98 Area-%Colore e forma:PowderPeso molecolare:388.11 g/molUNC 3230
CAS:<p>Inhibitor of PIP5K1C</p>Formula:C17H20N4O2SPurezza:Min. 95%Colore e forma:SolidPeso molecolare:344.43 g/molIrinotecan hydrochloride trihydrate - Bio-X ™
CAS:Irinotecan hydrochloride trihydrate is a topoisomerase I inhibitor that is used as chemotherapy drug for colorectal cancer. By inhibiting topoisomerase I, Irinotecan hydrochloride trihydrate prevents the replication of DNA in cells, and stops the cancer cells from growing and dividing. When used for chemotherapy, Irinotecan hydrochloride trihydrate is usually part of combination therapy with other chemotherapy drugs, such as 5-fluorouracil (5-FU) and leucovorin for other cancers.Formula:C33H38N4O6•HCl•(H2O)3Purezza:Min. 95%Colore e forma:PowderPeso molecolare:677.18 g/molLenvatinib base - Bio-X ™
CAS:<p>Lenvatinib is a tyrosine kinase inhibitor that is used to treat cancers such as solid tumours. This drug inhibits the activity of VEGR receptors. It also inhibits other receptors such as fibroblast growth factor.</p>Formula:C21H19ClN4O4Purezza:Min. 95%Colore e forma:PowderPeso molecolare:426.85 g/molTandutinib
CAS:<p>Tyrosine kinase inhibitor; antineoplastic activity; pro-apoptotic</p>Formula:C31H42N6O4Purezza:Min. 95%Colore e forma:PowderPeso molecolare:562.7 g/molVorinostat - Bio-X ™
CAS:<p>Vorinostat is a histone deacetylase inhibitor which interferes with gene transcription regulatory mechanisms. It is used to treat cutaneous manifestations in patients with progressive, persistent, or recurrent cutaneous T- cell lymphoma (CTCL) following prior systemic therapies. This drug inhibits the enzymatic activity of histone deacetylases HDAC1, HDAC2 and HDAC3 (Class I) and HDAC6 (Class II).</p>Formula:C14H20N2O3Purezza:Min. 99 Area-%Colore e forma:PowderPeso molecolare:264.32 g/molDarapladib
CAS:<p>Inhibitor of lipoprotein-associated phospholipase A2</p>Formula:C36H38F4N4O2SPurezza:Min. 98 Area-%Colore e forma:PowderPeso molecolare:666.77 g/molQuizartinib
CAS:<p>Inhibitor of FLT3 receptor tyrosine kinases; anti-neoplastic</p>Formula:C29H32N6O4SPurezza:Min. 95%Colore e forma:White PowderPeso molecolare:560.67 g/molAzaserine
CAS:<p>Glutamine analogue and antagonist of glutamine-dependent amidotransferases, with antibiotic and antifungal properties. Inhibits purine biosynthesis, FGAM synthetase and glucosamine-6-phosphate isomerase that contributes to its antineoplastic property. Azaserine can also act as a carcinogen, by inducing DNA carboxymethylation. Protects endothelial cells from inflammation under hyperglycemic conditions, via antioxidant mechanisms, independent of hexosamine biosynthetic pathway.</p>Formula:C5H7N3O4Purezza:Min. 98 Area-%Colore e forma:Slightly Yellow PowderPeso molecolare:173.13 g/mol
